Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to -$330000.0.

  • Puma Biotechnology's Non Operating Income rose 7756.63% to -$330000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 6579.59%. This contributed to the annual value of -$6.9 million for FY2024, which is 3110.58% up from last year.
  • Puma Biotechnology's Non Operating Income amounted to -$330000.0 in Q3 2025, which was up 7756.63% from -$471000.0 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Non Operating Income high stood at $11.6 million for Q2 2021, and its period low was -$35.7 million during Q3 2021.
  • Moreover, its 5-year median value for Non Operating Income was -$2.4 million (2021), whereas its average is -$3.8 million.
  • In the last 5 years, Puma Biotechnology's Non Operating Income surged by 40972.15% in 2021 and then crashed by 53973.29% in 2022.
  • Puma Biotechnology's Non Operating Income (Quarter) stood at -$2.4 million in 2021, then tumbled by 539.73% to -$15.3 million in 2022, then surged by 86.99% to -$2.0 million in 2023, then surged by 43.48% to -$1.1 million in 2024, then skyrocketed by 70.72% to -$330000.0 in 2025.
  • Its Non Operating Income was -$330000.0 in Q3 2025, compared to -$471000.0 in Q2 2025 and -$717000.0 in Q1 2025.